2024
|
Invention
|
Pharmaceutical composition for the treatment of cancer.
The present disclosure discloses a pharm... |
|
Invention
|
Treating cancer with an adenosine a 2a inhibitor. Methods for treating cancers, including solid t... |
2022
|
Invention
|
Tricyclic compounds, compositions and medicinal applications thereof.
Formula I
|
2019
|
Invention
|
Tricyclic compounds, compositions and medicinal applications thereof. The present disclosure rela... |
2018
|
Invention
|
Pharmaceutical composition for the treatment of cancer. The present disclosure discloses a pharma... |
|
Invention
|
Pharmaceutical composition for the treatment of cancer. 2A2B2B receptor. It further discloses the... |
|
Invention
|
Fused bicyclic compounds, compositions and applications thereof. Fused bicyclic compounds are inh... |
|
Invention
|
Fused bicyclic compounds, compositions and applications thereof. The present invention relates to... |
2016
|
Invention
|
Bridgehead nitrogen bicyclic inhibitors/modulators of retinoic acid-related orphan receptor gamma... |
2014
|
Invention
|
Substituted fused pyrimidine compounds. The present invention discloses substituted fused pyrimid... |
|
Invention
|
Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof. The prese... |
2013
|
Invention
|
Spirocyclic compounds, compositions and medicinal applications thereof. The present disclosure re... |
|
Invention
|
Substituted fused tricyclic compounds, compositions, and medicinal applications thereof. The pres... |
|
Invention
|
Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof in medical... |
2012
|
Invention
|
Substituted fused tricyclic compounds, compositions and medicinal applications thereof. The prese... |
|
Invention
|
Acetamide derivatives as glucokinase activators, their process and medicinal applications. Acetam... |
2011
|
Invention
|
Fused tricyclic compounds as adenosine receptor antagonist. The present disclosure relates to fus... |
|
Invention
|
Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal a... |
2010
|
Invention
|
Substituted fused pyrimidine compounds, its preparation and uses thereof. The present invention p... |
2009
|
Invention
|
Heterocyclic compounds as adenosine receptor antagonist. Compounds of the present disclosure are ... |
2008
|
Invention
|
Acetamide derivatives as glucokinase activators, their process and medicinal application. Acetami... |
|
Invention
|
2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmace... |